RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications.

Printable list of studies

Download Annual Studies PDF

Use the search box below to find key terms in research papers. For category-specific or recommended results, use the dropdown lists provided.
Research title with ★ indicates InBody recommended paper.

Effects of ipragliflozin on postprandial glucose metabolism and gut peptides in type 2 diabetes: a pilot study

Endocrinology
Author
H Ueno et al.
Used Parameters : BW, BMI, TBW, Muscle Mass, BFM, PBF
Publication Year : 2018
Country : Japan
Journal : Diabetes Therapy
Introduction Ipragliflozin is a novel antidiabetic drug that inhibits renal tubular sodium-glucose cotransporter-2 (SGLT2). The aim of this study was to evaluate the effects of ipragliflozin on glucose, insulin, glucagon, and gastrointestinal peptide responses to a meal tolerance test, as well as to investigate the glucose-lowering mechanisms of ipragliflozin. Methods Nine Japanese patients with obesity and type 2 diabetes mellitus were treated with ipragliflozin (50 mg/day) for 12 weeks. The postprandial profiles of glucose, insulin …
Full text
Sequential changes of body composition in patients with enterocutaneous fistula during the 10 days after admission »
List
Powered by KBoard